Free Trial

Morgan Stanley Emerging Markets Debt Fund (MSD) Competitors

Morgan Stanley Emerging Markets Debt Fund logo
$7.39 +0.04 (+0.54%)
As of 03:03 PM Eastern
This is a fair market value price provided by Massive. Learn more.

MSD vs. ECC, HQL, TWN, IFN, and CCAP

Should you be buying Morgan Stanley Emerging Markets Debt Fund stock or one of its competitors? The main competitors of Morgan Stanley Emerging Markets Debt Fund include Eagle Point Credit (ECC), abrdn Life Sciences Investors (HQL), Taiwan Fund (TWN), India Fund (IFN), and Crescent Capital BDC (CCAP). These companies are all part of the "financial services" industry.

How does Morgan Stanley Emerging Markets Debt Fund compare to Eagle Point Credit?

Morgan Stanley Emerging Markets Debt Fund (NYSE:MSD) and Eagle Point Credit (NYSE:ECC) are both small-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

Morgan Stanley Emerging Markets Debt Fund pays an annual dividend of $0.65 per share and has a dividend yield of 8.8%. Eagle Point Credit pays an annual dividend of $1.66 per share and has a dividend yield of 39.3%. Eagle Point Credit pays out 873.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Eagle Point Credit has a net margin of 12.33% compared to Morgan Stanley Emerging Markets Debt Fund's net margin of 0.00%. Eagle Point Credit's return on equity of 13.47% beat Morgan Stanley Emerging Markets Debt Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
Morgan Stanley Emerging Markets Debt FundN/A N/A N/A
Eagle Point Credit 12.33%13.47%8.14%

Eagle Point Credit has a consensus target price of $6.67, suggesting a potential upside of 57.79%. Given Eagle Point Credit's stronger consensus rating and higher possible upside, analysts clearly believe Eagle Point Credit is more favorable than Morgan Stanley Emerging Markets Debt Fund.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Morgan Stanley Emerging Markets Debt Fund
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Eagle Point Credit
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

19.5% of Eagle Point Credit shares are held by institutional investors. 0.3% of Eagle Point Credit shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Eagle Point Credit had 1 more articles in the media than Morgan Stanley Emerging Markets Debt Fund. MarketBeat recorded 1 mentions for Eagle Point Credit and 0 mentions for Morgan Stanley Emerging Markets Debt Fund. Eagle Point Credit's average media sentiment score of 1.64 beat Morgan Stanley Emerging Markets Debt Fund's score of 0.00 indicating that Eagle Point Credit is being referred to more favorably in the news media.

Company Overall Sentiment
Morgan Stanley Emerging Markets Debt Fund Neutral
Eagle Point Credit Very Positive

Morgan Stanley Emerging Markets Debt Fund has higher revenue and earnings than Eagle Point Credit.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Morgan Stanley Emerging Markets Debt Fund$21.69M6.91N/AN/AN/A
Eagle Point Credit-$125.96M-4.43-$115M$0.1922.24

Morgan Stanley Emerging Markets Debt Fund has a beta of 0.56, indicating that its stock price is 44% less volatile than the S&P 500. Comparatively, Eagle Point Credit has a beta of 0.35, indicating that its stock price is 65% less volatile than the S&P 500.

Summary

Eagle Point Credit beats Morgan Stanley Emerging Markets Debt Fund on 11 of the 15 factors compared between the two stocks.

How does Morgan Stanley Emerging Markets Debt Fund compare to abrdn Life Sciences Investors?

abrdn Life Sciences Investors (NYSE:HQL) and Morgan Stanley Emerging Markets Debt Fund (NYSE:MSD) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, media sentiment, valuation, risk, dividends and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
abrdn Life Sciences InvestorsN/A N/A N/A
Morgan Stanley Emerging Markets Debt Fund N/A N/A N/A

In the previous week, abrdn Life Sciences Investors' average media sentiment score of 0.00 equaled Morgan Stanley Emerging Markets Debt Fund'saverage media sentiment score.

abrdn Life Sciences Investors pays an annual dividend of $1.91 per share and has a dividend yield of 10.7%. Morgan Stanley Emerging Markets Debt Fund pays an annual dividend of $0.65 per share and has a dividend yield of 8.8%.

abrdn Life Sciences Investors has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500. Comparatively, Morgan Stanley Emerging Markets Debt Fund has a beta of 0.56, indicating that its share price is 44% less volatile than the S&P 500.

32.2% of abrdn Life Sciences Investors shares are held by institutional investors. 10.1% of abrdn Life Sciences Investors shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
abrdn Life Sciences Investors$86.39M6.29N/AN/AN/A
Morgan Stanley Emerging Markets Debt Fund$21.69M6.91N/AN/AN/A

Summary

abrdn Life Sciences Investors beats Morgan Stanley Emerging Markets Debt Fund on 5 of the 6 factors compared between the two stocks.

How does Morgan Stanley Emerging Markets Debt Fund compare to Taiwan Fund?

Morgan Stanley Emerging Markets Debt Fund (NYSE:MSD) and Taiwan Fund (NYSE:TWN) are both small-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, media sentiment, analyst recommendations and profitability.

Company Net Margins Return on Equity Return on Assets
Morgan Stanley Emerging Markets Debt FundN/A N/A N/A
Taiwan Fund N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Morgan Stanley Emerging Markets Debt Fund$21.69M6.91N/AN/AN/A
Taiwan Fund$75.23M7.41N/AN/AN/A

In the previous week, Taiwan Fund had 1 more articles in the media than Morgan Stanley Emerging Markets Debt Fund. MarketBeat recorded 1 mentions for Taiwan Fund and 0 mentions for Morgan Stanley Emerging Markets Debt Fund. Taiwan Fund's average media sentiment score of 0.29 beat Morgan Stanley Emerging Markets Debt Fund's score of 0.00 indicating that Taiwan Fund is being referred to more favorably in the news media.

Company Overall Sentiment
Morgan Stanley Emerging Markets Debt Fund Neutral
Taiwan Fund Neutral

Morgan Stanley Emerging Markets Debt Fund pays an annual dividend of $0.65 per share and has a dividend yield of 8.8%. Taiwan Fund pays an annual dividend of $6.20 per share and has a dividend yield of 6.4%.

Morgan Stanley Emerging Markets Debt Fund has a beta of 0.56, suggesting that its share price is 44% less volatile than the S&P 500. Comparatively, Taiwan Fund has a beta of 1.42, suggesting that its share price is 42% more volatile than the S&P 500.

Summary

Taiwan Fund beats Morgan Stanley Emerging Markets Debt Fund on 5 of the 6 factors compared between the two stocks.

How does Morgan Stanley Emerging Markets Debt Fund compare to India Fund?

India Fund (NYSE:IFN) and Morgan Stanley Emerging Markets Debt Fund (NYSE:MSD) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, earnings, dividends, profitability, valuation and risk.

10.8% of India Fund shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
India FundN/AN/AN/AN/AN/A
Morgan Stanley Emerging Markets Debt Fund$21.69M6.91N/AN/AN/A

Company Net Margins Return on Equity Return on Assets
India FundN/A N/A N/A
Morgan Stanley Emerging Markets Debt Fund N/A N/A N/A

In the previous week, India Fund had 1 more articles in the media than Morgan Stanley Emerging Markets Debt Fund. MarketBeat recorded 1 mentions for India Fund and 0 mentions for Morgan Stanley Emerging Markets Debt Fund. India Fund's average media sentiment score of 0.00 equaled Morgan Stanley Emerging Markets Debt Fund'saverage media sentiment score.

Company Overall Sentiment
India Fund Neutral
Morgan Stanley Emerging Markets Debt Fund Neutral

India Fund pays an annual dividend of $2.20 per share and has a dividend yield of 18.7%. Morgan Stanley Emerging Markets Debt Fund pays an annual dividend of $0.65 per share and has a dividend yield of 8.8%.

India Fund has a beta of 0.71, indicating that its stock price is 29% less volatile than the S&P 500. Comparatively, Morgan Stanley Emerging Markets Debt Fund has a beta of 0.56, indicating that its stock price is 44% less volatile than the S&P 500.

Summary

India Fund beats Morgan Stanley Emerging Markets Debt Fund on 4 of the 5 factors compared between the two stocks.

How does Morgan Stanley Emerging Markets Debt Fund compare to Crescent Capital BDC?

Morgan Stanley Emerging Markets Debt Fund (NYSE:MSD) and Crescent Capital BDC (NASDAQ:CCAP) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, profitability, dividends, valuation and analyst recommendations.

Morgan Stanley Emerging Markets Debt Fund has a beta of 0.56, meaning that its stock price is 44% less volatile than the S&P 500. Comparatively, Crescent Capital BDC has a beta of 0.59, meaning that its stock price is 41% less volatile than the S&P 500.

Morgan Stanley Emerging Markets Debt Fund pays an annual dividend of $0.65 per share and has a dividend yield of 8.8%. Crescent Capital BDC pays an annual dividend of $1.68 per share and has a dividend yield of 12.1%. Crescent Capital BDC pays out 178.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has increased its dividend for 1 consecutive years. Crescent Capital BDC is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Crescent Capital BDC has a consensus price target of $15.50, indicating a potential upside of 11.80%. Given Crescent Capital BDC's stronger consensus rating and higher possible upside, analysts clearly believe Crescent Capital BDC is more favorable than Morgan Stanley Emerging Markets Debt Fund.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Morgan Stanley Emerging Markets Debt Fund
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Crescent Capital BDC
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.71

Crescent Capital BDC has a net margin of 20.64% compared to Morgan Stanley Emerging Markets Debt Fund's net margin of 0.00%. Crescent Capital BDC's return on equity of 9.32% beat Morgan Stanley Emerging Markets Debt Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
Morgan Stanley Emerging Markets Debt FundN/A N/A N/A
Crescent Capital BDC 20.64%9.32%4.07%

In the previous week, Crescent Capital BDC had 2 more articles in the media than Morgan Stanley Emerging Markets Debt Fund. MarketBeat recorded 2 mentions for Crescent Capital BDC and 0 mentions for Morgan Stanley Emerging Markets Debt Fund. Morgan Stanley Emerging Markets Debt Fund's average media sentiment score of 0.00 equaled Crescent Capital BDC'saverage media sentiment score.

Company Overall Sentiment
Morgan Stanley Emerging Markets Debt Fund Neutral
Crescent Capital BDC Neutral

49.5% of Crescent Capital BDC shares are owned by institutional investors. 1.2% of Crescent Capital BDC shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Crescent Capital BDC has higher revenue and earnings than Morgan Stanley Emerging Markets Debt Fund.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Morgan Stanley Emerging Markets Debt Fund$21.69M6.91N/AN/AN/A
Crescent Capital BDC$167.29M3.06$34.51M$0.9414.75

Summary

Crescent Capital BDC beats Morgan Stanley Emerging Markets Debt Fund on 14 of the 16 factors compared between the two stocks.

Get Morgan Stanley Emerging Markets Debt Fund News Delivered to You Automatically

Sign up to receive the latest news and ratings for MSD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MSD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MSD vs. The Competition

MetricMorgan Stanley Emerging Markets Debt FundFIN IndustryFinance SectorNYSE Exchange
Market Cap$149.90M$4.42B$13.40B$23.00B
Dividend Yield8.81%7.20%5.77%4.03%
P/E RatioN/A0.0623.3628.59
Price / Sales6.9152.44178.0723.63
Price / CashN/A5.5119.7219.03
Price / BookN/A3.302.214.69
Net IncomeN/A$388.27M$1.11B$1.07B
7 Day Performance0.41%0.67%0.06%0.97%
1 Month Performance4.93%3.73%4.68%6.63%
1 Year Performance-1.92%14.81%13.67%31.82%

Morgan Stanley Emerging Markets Debt Fund Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MSD
Morgan Stanley Emerging Markets Debt Fund
N/A$7.39
+0.5%
N/AN/A$149.90M$21.69MN/AN/A
ECC
Eagle Point Credit
4.8284 of 5 stars
$4.03
+0.1%
$6.67
+65.6%
N/A$532.14M-$125.96M21.19N/A
HQL
abrdn Life Sciences Investors
N/A$17.38
-0.9%
N/AN/A$528.49M$86.39MN/AN/A
TWN
Taiwan Fund
N/A$89.34
+0.2%
N/AN/A$517.48M$75.23MN/AN/A
IFN
India Fund
N/A$12.05
-0.1%
N/AN/A$513.93MN/AN/A21,000

Related Companies and Tools


This page (NYSE:MSD) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners